Give your career a boost by gaining experience from collaboration with leading academic and industrial research groups and expanding your expertise in computational analysis of high-dimensional tissue, cell and molecular profiling data and mathematical modeling of dynamical biological systems.
Have a real impact by advancing Celgene's patient-focused Molecular Medicine and Immuno-Oncology efforts to discover and develop new therapies that will effectively and optimally change the course of human health. Your research findings will directly enhance the scientific community through publications and be meaningfully applied to the discovery of novel medicines.
Prepare yourself to be challenged, excited and inspired.
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries - and growing we look for talented people to grow our business, advance our science and contribute to our unique culture.
Postdoctoral Position at Celgene (Seattle, WA)
We seek a talented, collaborative interdisciplinary scientist to catalyze the development and application of computational approaches for the analysis of high-dimensional cell and molecular profiling data and integrative modeling of multiscale dynamical biological systems. The successful candidate will work on computational analysis of large multi-omics datasets (including genomics, transcriptomics, proteomics, and phenomics) and mathematical modeling of complex biological systems.
This role will be also expected to participate in collaborative projects with Seattle-based leading academic research groups on computational analysis of high-dimensional tissue, cell and molecular profiling data to advance Celgene's patient-focused Molecular Medicine and Immuno-Oncology efforts.
Expertise in predictive pattern recognition applied to molecular profiling data and mathematical modeling of biological and disease processes, and demonstrable ability to interpret the output of such analyses in the clinical context, are prerequisite.
A Ph.D. in computational biology, bioinformatics, computer science, or related disciplines is required.
- Expertise in analysis, interpretation and applied computational research on large multivariate molecular profiling datasets.
- Experience with mathematical kinetic modeling of dynamical biological systems.
- Experience analyzing human and/or other organism datasets at scale.
- Experience developing and integrating data analysis tools to manipulate large datasets.
- Experience in machine learning, biostatistics, and sequence analysis.
- Experience with relevant scripting tools (e.g. R, MATLAB, Python, C/C++).
- A track record demonstrating scientific creativity, collaboration, and independence.
- Excellent written and oral communication skills.
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.
Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.
REQ ID: 16000962
PRIMARY LOCATION: United States-Washington-Seattle
JOB: Research and Early Development
ORGANIZATION: Celgene Corporation
SCHEDULE: Limited Term
EMPLOYEE STATUS: Individual Contributor
JOB TYPE: Full-time
JOB LEVEL: Day Job
JOB POSTING: 2016-12-05 00:00:00.0
Website : http://www.celgene.com
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.